U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07847112) titled 'Soluble TREM-1 in Diabetes-Associated Cardiovascular Complications' on Sept. 23.
Brief Summary: Cardiovascular disease is the leading cause of illness and death among individuals with type 2 diabetes mellitus (T2DM). Chronic low-grade inflammation contributes significantly to blood vessel damage, atherosclerosis, and diabetic heart complications. Although conventional inflammatory markers such as high-sensitivity C-reactive protein (hs-CRP) and ferritin are commonly measured, they lack specificity and can be altered by various other health conditions. Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) is an innate i...